查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1423672

2030 年神经刺激设备市场预测：按产品、设备类型、疾病状况、应用、最终用户和地区进行的全球分析

Neurostimulation Devices Market Forecasts to 2030 - Global Analysis By Product (Closed-Loop Stimulation Systems, Deep Brain Stimulation and Other Products), By Device Type, Disease Pathology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

2023年全球神经刺激设备市场价值为78.8亿美元，预计2030年将达到188.9亿美元，预测期内复合年增长率为13.3%。神经刺激设备是一种专门的仪器，旨在透过电或化学手段调节神经系统的活动。这些设备旨在针对特定神经或大脑区域，并透过电或化学手段调节神经活动。这些设备透过提供受控刺激来帮助缓解症状并改善患者的生活质量，从而治疗慢性疼痛、运动障碍、癫痫和忧郁症神经系统疾病。

根据癫痫中心发布的消息，目前癫痫患者总数约5000万，每年新增癫痫病例约240万例。

慢性病增加

慢性疼痛症候群等慢性疾病和帕金森氏症、癫痫和抗治疗性忧郁症等神经系统忧郁症的盛行率不断上升，是神经刺激设备市场的关键驱动因素。神经刺激设备提供了一种创新方法并有效缓解症状。全球受这些慢性病影响的人数不断增加，对先进非药物疗法的需求不断增加，推动了神经刺激设备作为可行治疗解决方案的成长和采用。

设备成本高且保险范围有限

这些先进设备通常需要大量初始投资，限制了患者的使用并造成了财务障碍。此外，某些地区的保险覆盖范围和报销政策不佳限制了患者的负担能力和医疗保健提供者的招募。由于患者数量减少、医疗设施投资减少以及神经刺激设备普及速度放缓，这种情况将影响市场成长。

个人化治疗方案的进步

创新技术和精准医疗方法可以根据患者的个别需求客製化治疗方法，从而实现更有针对性的干预措施。个人化治疗考虑了患者的解剖结构、神经反应和症状严重程度等因素，可以提高疗效，同时减少副作用。这一趋势不仅改善了患者的治疗效果和满意度，还促进了可自订神经刺激设备的市场开拓，满足多样化的患者需求，拓宽了市场的潜在基础，促进了成长。

主要企业之间竞争激烈

主要企业之间的激烈竞争可能会带来潜在的市场饱和和定价压力。随着多家公司争夺市场占有率，创新至关重要，现有技术可能会更快过时。此外，为获得竞争优势而采取的积极定价策略可能会影响盈利并阻碍研发投资。这种竞争性的市场环境还会增加行销成本、阻碍中小企业进入、增强市场力量并抑制创新。

COVID-19 的影响：

COVID-19 大流行导致选择性手术（包括设备植入手术）的延误，扰乱了神经刺激设备市场。由于医院容量下降，医疗保健资源被用于应对流感大流行，治疗被推迟，设备普及速度减慢。供应链中断和物流挑战进一步影响了製造和分销，影响了神经刺激设备的可用性，从而影响了大流行期间的市场成长。

神经血栓切除术设备领域预计将在预测期内成为最大的领域

由于中风和血栓性疾病的增加，神经血栓切除设备领域预计将主导市场。血栓回收系统、抽吸装置和勒除器的技术进步为清除脑动脉中的血块提供了微创解决方案，这对于治疗急性缺血性脑中风至关重要。随着人们越来越认识到神经血栓切除术在改善患者预后方面的有效性，再加上有利的报销政策，该细分市场正在解决中风管理中未满足的需求，并将自己定位为神经刺激设备市场的关键参与者。它已经确立了自己的地位，并预计将增长显着。

预计忧郁症产业在预测期内复合年增长率最高

由于意识的提高、患者群体的扩大以及对抗药性忧郁症替代疗法的需求，忧郁症领域预计将出现最高的市场成长率。神经调节技术的不断进步，例如深部脑部刺激（DBS）和经颅磁刺激（TMS），在缓解忧郁症状方面取得了可喜的成果。随着人们对心理健康的兴趣日益浓厚以及对非药物干预措施的偏好，忧郁症领域预计将在预测期内快速普及并实现显着的市场成长。

比最大的地区

由于其强大的医疗基础设施、高额研发投资以及较早采用创新技术，北美预计将获得最大的市场占有率。该地区是知名市场参与者的所在地，并享有优惠的报销政策，支持神经刺激疗法的普及。此外，神经系统疾病的盛行率不断上升，加上积极努力解决慢性疾病，使北美处于神经刺激设备产业的前沿，推动了市场的显着成长和主导地位。

复合年增长率最高的地区：

由于医疗保健支出增加、研发活动扩大以及易患神经病变的老年人口增加，欧洲将在神经刺激设备市场经历最高的复合年增长率。有利的报销政策和积极采用创新医疗技术的方法进一步促进了这一增长。此外，医疗保健专业人员和患者对神经刺激设备益处的认识不断提高，正在推动该地区的市场扩张。

提供免费客製化：

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次调查来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 应用分析
  • 最终用户分析
  • COVID-19 的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球神经刺激设备市场：副产品

  • 封闭回路型刺激系统
  • 深部脑部刺激（DBS）
  • 运动皮质刺激 (MCS)
  • 荐椎神经刺激(SNS)
  • 脊髓刺激 (SCS)
  • 三叉神经刺激（TNS）
  • 迷走神经刺激 (VNS)
  • 其他产品

第六章全球神经刺激设备市场：依设备类型

  • 动脉瘤弹簧圈栓塞装置
    • 栓塞圈
      • 裸露的可拆卸线圈
      • 涂层可拆线圈
    • 导流装置
    • 液态栓塞剂
  • 脑球囊血管成形术和支架系统
    • 球囊导管
    • 颈动脉支架
  • 神经血栓切除装置
    • 血栓采集
    • 抽吸及抽吸装置
    • 勒除器
  • 其他设备类型

第七章全球神经刺激设备市场：依疾病状况

  • 动静脉畸形和瘻管
  • 颈动脉狭窄
  • 脑动脉瘤
  • 缺血性中风
  • 其他疾病

第八章全球神经刺激设备市场：依应用分类

  • 忧郁症
  • 肌张力不全症
  • 癫痫
  • 胃轻瘫
  • 疼痛管理
  • 帕金森氏症
  • 发抖
  • 尿失禁和大便失禁
  • 其他用途

第九章全球神经刺激设备市场：依最终用户分类

  • 医院
  • 失智症护理中心
  • 专科诊所
  • 调查机构
  • 其他最终用户

第十章全球神经刺激设备市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东/非洲

第十一章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十二章 公司简介

  • Abbott Laboratories
  • Axonics Modulation Technologies
  • BioControl Medical
  • Boston Scientific Corporation
  • LivaNova
  • Mainstay Medical
  • Medtronic
  • Merck & Co., Inc
  • MicroTransponder
  • Neuronetics
  • NeuroPace
  • Nevro Corp
  • Nexeon MedSystems
  • Saluda Medical
  • Soterix Medical
  • SPR Therapeutics
  • Stimwave Technologies
  • Synapse Biomedical
  • Zynex Medical
Product Code: SMRC24906

According to Stratistics MRC, the Global Neurostimulation Devices Market is accounted for $7.88 billion in 2023 and is expected to reach $18.89 billion by 2030 growing at a CAGR of 13.3% during the forecast period. Neurostimulation devices are specialised instruments designed to modulate the nervous system's activity through electrical or chemical means. Implanted or applied externally, these devices target specific nerves or brain regions, managing neurological conditions like chronic pain, movement disorders, epilepsy, or depression by delivering controlled stimulation, aiding in symptom alleviation and enhancing the patient's quality of life.

According to the information distributed by the Epilepsy Center, by and by, around 50 million patients are living with epilepsy overall and around 2.4 million new cases are analyzed yearly.

Market Dynamics:

Driver:

Increasing prevalence of chronic disorders

The rising prevalence of chronic disorders, such as chronic pain syndromes and neurological conditions like Parkinson's disease, epilepsy and treatment-resistant depression, acts as a significant driver in the neurostimulation device market. Neurostimulation devices offer an innovative approach, providing effective symptom relief. With an increasing population affected by these chronic ailments globally, there's heightened demand for advanced, non-pharmacological treatments, propelling the growth and adoption of neurostimulation devices as viable therapeutic solutions.

Restraint:

High device costs and limited insurance coverage

The substantial initial investment required for these advanced devices often limits patient access, creating financial barriers. Additionally, inadequate insurance coverage or reimbursement policies in certain regions restrict patient affordability and healthcare provider adoption. This situation impacts market growth by reducing patient pool sizes and healthcare facility investments, slowing down the adoption rate of neurostimulation devices.

Opportunity:

Advancements in personalized treatment options

Tailoring therapies to individual patient needs through innovative technologies and precision medicine approaches allows for more targeted interventions. Personalised treatments, considering factors like patient anatomy, neural responses and condition severity, enhance efficacy while reducing adverse effects. This trend not only improves patient outcomes and satisfaction but also drives market growth by fostering the development of customisable neurostimulation devices, meeting the diverse needs of patients and expanding the market's potential reach.

Threat:

Intense competition among key players

Intense competition among key players poses a threat due to potential market saturation and pricing pressures. With multiple companies vying for market share, innovation becomes critical, potentially leading to the faster obsolescence of existing technologies. Moreover, aggressive pricing strategies to gain a competitive edge might impact profitability and hinder investment in research and development. This competition-driven environment may also elevate marketing costs and hinder smaller players' entry, consolidating market dominance and potentially stifling innovation.

Covid-19 Impact:

The COVID-19 pandemic disrupted the neurostimulation devices market by causing delays in elective surgeries, including device implantation procedures. Reduced hospital capacities and diverted healthcare resources towards managing the pandemic led to deferred treatments and slowed device adoption. Supply chain disruptions and logistical challenges further affected manufacturing and distribution, impacting the accessibility of neurostimulation devices and consequently affecting market growth during the pandemic period.

The neurothrombectomy devices segment is expected to be the largest during the forecast period

The neurothrombectomy devices segment is poised to dominate the market due to rising incidences of stroke and thrombotic conditions. Technological advancements in clot retrieval systems, suction devices and snares offer minimally invasive solutions for removing clots from cerebral arteries, vital in treating acute ischemic strokes. As awareness grows regarding the effectiveness of neurothrombectomy in improving patient outcomes, coupled with favorable reimbursement policies, this segment anticipates substantial growth, addressing an unmet need in stroke management and positioning itself as a pivotal player in the neurostimulation devices market.

The depression segment is expected to have the highest CAGR during the forecast period

The depression segment is projected to experience the highest growth rate in market due to increasing awareness, expanding patient populations and the demand for alternative treatments for medication-resistant depression. Continuous advancements in neuromodulation technologies, such as deep brain stimulation (DBS) and transcranial magnetic stimulation (TMS), offer promising outcomes in alleviating depressive symptoms. With a growing emphasis on mental health and a preference for non-pharmacological interventions, the depression segment is anticipated to witness rapid adoption and substantial market growth during the forecast period.

Region with largest share:

North America is set to secure the largest market share, due to its robust healthcare infrastructure, high investment in research and development and early adoption of innovative technologies. The region hosts prominent market players and enjoys favourable reimbursement policies, encouraging widespread adoption of neurostimulation therapies. Additionally, the increased prevalence of neurological disorders, coupled with a proactive approach towards addressing chronic conditions, positions North America at the forefront, driving substantial market growth and dominance in the neurostimulation devices industry.

Region with highest CAGR:

Europe is set to experience the highest CAGR in the neurostimulation devices market, owing to the increased healthcare expenditure, expanding R&D activities, and a growing geriatric population susceptible to neurological disorders. Favourable reimbursement policies and a proactive approach to adopting innovative medical technologies further contribute to this growth. Additionally, rising awareness among both healthcare providers and patients about the benefits of neurostimulation devices propels market expansion in the region.

Key players in the market

Some of the key players in Neurostimulation Devices Market include Abbott Laboratories, Axonics Modulation Technologies, BioControl Medical, Boston Scientific Corporation, LivaNova, Mainstay Medical, Medtronic, Merck & Co., Inc, MicroTransponder, Neuronetics, NeuroPace, Nevro Corp, Nexeon MedSystems, Saluda Medical, Soterix Medical, SPR Therapeutics, Stimwave Technologies, Synapse Biomedical and Zynex Medical.

Key Developments:

In May 2023, Abbott received FDA approval for its spinal cord stimulation (SCS) systems for treating chronic back pain in people who have not had or are not eligible to receive back surgery, known as non-surgical back pain. This new indication applies to all Abbott's SCS products in the United States, including the Eterna SCS platform and the Proclaim SCS family.

In August 2022, Merck announced a collaboration in its new Bioelectronics innovation field with neuroloop GmbH, a B. Braun subsidiary, to develop a neurostimulator device that can complement the existing drug therapies of patients with chronic inflammatory diseases.

Products Covered:

  • Closed-Loop Stimulation Systems
  • Deep Brain Stimulation (DBS)
  • Motor Cortex Stimulation (MCS)
  • Sacral Nerve Stimulation (SNS)
  • Spinal Cord Stimulation (SCS)
  • Trigeminal Nerve Stimulation (TNS)
  • Vagus Nerve Stimulation (VNS)
  • Other Products

Device Types Covered:

  • Aneurysm Coiling & Embolization Devices
  • Cerebral balloon angioplasty & Stenting systems
  • Neurothrombectomy Devices

Disease Pathologies Covered:

  • Arteriovenous Malformations and Fistulas
  • Carotid Artery Stenosis
  • Cerebral Aneuryms
  • Ischemic Strokes
  • Other Diseases

Applications Covered:

  • Depression
  • Dystonia
  • Epilepsy
  • Gastroparesis
  • Pain Management
  • Parkinson's Disease
  • Tremors
  • Urinary and Fecal Incontinence
  • Other Applications

End Users Covered:

  • Hospitals
  • Cognitive Care Centers
  • Specialty Clinics
  • Research Institutes
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Neurostimulation Devices Market, By Product

  • 5.1 Introduction
  • 5.2 Closed-Loop Stimulation Systems
  • 5.3 Deep Brain Stimulation (DBS)
  • 5.4 Motor Cortex Stimulation (MCS)
  • 5.5 Sacral Nerve Stimulation (SNS)
  • 5.6 Spinal Cord Stimulation (SCS)
  • 5.7 Trigeminal Nerve Stimulation (TNS)
  • 5.8 Vagus Nerve Stimulation (VNS)
  • 5.9 Other Products

6 Global Neurostimulation Devices Market, By Device Type

  • 6.1 Introduction
  • 6.2 Aneurysm Coiling & Embolization Devices
    • 6.2.1 Embolic Coils
      • 6.2.1.1 Bare Detachable Coils
      • 6.2.1.2 Coated Detachable Coils
    • 6.2.2 Flow Diversion Devices
    • 6.2.3 Liquid Embolic Agents
  • 6.3 Cerebral balloon angioplasty & Stenting systems
    • 6.3.1 Balloon Catheters
    • 6.3.2 Carotid Artery Stents
  • 6.4 Neurothrombectomy Devices
    • 6.4.1 Clot Retrievals
    • 6.4.2 Suction & Aspiration Devices
    • 6.4.3 Snares
  • 6.5 Other Device Types

7 Global Neurostimulation Devices Market, By Disease Pathology

  • 7.1 Introduction
  • 7.2 Arteriovenous Malformations and Fistulas
  • 7.3 Carotid Artery Stenosis
  • 7.4 Cerebral Aneuryms
  • 7.5 Ischemic Strokes
  • 7.6 Other Diseases

8 Global Neurostimulation Devices Market, By Application

  • 8.1 Introduction
  • 8.2 Depression
  • 8.3 Dystonia
  • 8.4 Epilepsy
  • 8.5 Gastroparesis
  • 8.6 Pain Management
  • 8.7 Parkinson's Disease
  • 8.8 Tremors
  • 8.9 Urinary and Fecal Incontinence
  • 8.10 Other Applications

9 Global Neurostimulation Devices Market, By End User

  • 9.1 Introduction
  • 9.2 Hospitals
  • 9.3 Cognitive Care Centers
  • 9.4 Specialty Clinics
  • 9.5 Research Institutes
  • 9.6 Other End Users

10 Global Neurostimulation Devices Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Abbott Laboratories
  • 12.2 Axonics Modulation Technologies
  • 12.3 BioControl Medical
  • 12.4 Boston Scientific Corporation
  • 12.5 LivaNova
  • 12.6 Mainstay Medical
  • 12.7 Medtronic
  • 12.8 Merck & Co., Inc
  • 12.9 MicroTransponder
  • 12.10 Neuronetics
  • 12.11 NeuroPace
  • 12.12 Nevro Corp
  • 12.13 Nexeon MedSystems
  • 12.14 Saluda Medical
  • 12.15 Soterix Medical
  • 12.16 SPR Therapeutics
  • 12.17 Stimwave Technologies
  • 12.18 Synapse Biomedical
  • 12.19 Zynex Medical

List of Tables

  • Table 1 Global Neurostimulation Devices Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Neurostimulation Devices Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Neurostimulation Devices Market Outlook, By Closed-Loop Stimulation Systems (2021-2030) ($MN)
  • Table 4 Global Neurostimulation Devices Market Outlook, By Deep Brain Stimulation (DBS) (2021-2030) ($MN)
  • Table 5 Global Neurostimulation Devices Market Outlook, By Motor Cortex Stimulation (MCS) (2021-2030) ($MN)
  • Table 6 Global Neurostimulation Devices Market Outlook, By Sacral Nerve Stimulation (SNS) (2021-2030) ($MN)
  • Table 7 Global Neurostimulation Devices Market Outlook, By Spinal Cord Stimulation (SCS) (2021-2030) ($MN)
  • Table 8 Global Neurostimulation Devices Market Outlook, By Trigeminal Nerve Stimulation (TNS) (2021-2030) ($MN)
  • Table 9 Global Neurostimulation Devices Market Outlook, By Vagus Nerve Stimulation (VNS) (2021-2030) ($MN)
  • Table 10 Global Neurostimulation Devices Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 11 Global Neurostimulation Devices Market Outlook, By Device Type (2021-2030) ($MN)
  • Table 12 Global Neurostimulation Devices Market Outlook, By Aneurysm Coiling & Embolization Devices (2021-2030) ($MN)
  • Table 13 Global Neurostimulation Devices Market Outlook, By Embolic Coils (2021-2030) ($MN)
  • Table 14 Global Neurostimulation Devices Market Outlook, By Bare Detachable Coils (2021-2030) ($MN)
  • Table 15 Global Neurostimulation Devices Market Outlook, By Coated Detachable Coils (2021-2030) ($MN)
  • Table 16 Global Neurostimulation Devices Market Outlook, By Flow Diversion Devices (2021-2030) ($MN)
  • Table 17 Global Neurostimulation Devices Market Outlook, By Liquid Embolic Agents (2021-2030) ($MN)
  • Table 18 Global Neurostimulation Devices Market Outlook, By Cerebral balloon angioplasty & Stenting systems (2021-2030) ($MN)
  • Table 19 Global Neurostimulation Devices Market Outlook, By Balloon Catheters (2021-2030) ($MN)
  • Table 20 Global Neurostimulation Devices Market Outlook, By Carotid Artery Stents (2021-2030) ($MN)
  • Table 21 Global Neurostimulation Devices Market Outlook, By Neurothrombectomy Devices (2021-2030) ($MN)
  • Table 22 Global Neurostimulation Devices Market Outlook, By Clot Retrievals (2021-2030) ($MN)
  • Table 23 Global Neurostimulation Devices Market Outlook, By Suction & Aspiration Devices (2021-2030) ($MN)
  • Table 24 Global Neurostimulation Devices Market Outlook, By Snares (2021-2030) ($MN)
  • Table 25 Global Neurostimulation Devices Market Outlook, By Disease Pathology (2021-2030) ($MN)
  • Table 26 Global Neurostimulation Devices Market Outlook, By Arteriovenous Malformations and Fistulas (2021-2030) ($MN)
  • Table 27 Global Neurostimulation Devices Market Outlook, By Carotid Artery Stenosis (2021-2030) ($MN)
  • Table 28 Global Neurostimulation Devices Market Outlook, By Cerebral Aneuryms (2021-2030) ($MN)
  • Table 29 Global Neurostimulation Devices Market Outlook, By Ischemic Strokes (2021-2030) ($MN)
  • Table 30 Global Neurostimulation Devices Market Outlook, By Other Diseases (2021-2030) ($MN)
  • Table 31 Global Neurostimulation Devices Market Outlook, By Application (2021-2030) ($MN)
  • Table 32 Global Neurostimulation Devices Market Outlook, By Depression (2021-2030) ($MN)
  • Table 33 Global Neurostimulation Devices Market Outlook, By Dystonia (2021-2030) ($MN)
  • Table 34 Global Neurostimulation Devices Market Outlook, By Epilepsy (2021-2030) ($MN)
  • Table 35 Global Neurostimulation Devices Market Outlook, By Gastroparesis (2021-2030) ($MN)
  • Table 36 Global Neurostimulation Devices Market Outlook, By Pain Management (2021-2030) ($MN)
  • Table 37 Global Neurostimulation Devices Market Outlook, By Parkinson's Disease (2021-2030) ($MN)
  • Table 38 Global Neurostimulation Devices Market Outlook, By Tremors (2021-2030) ($MN)
  • Table 39 Global Neurostimulation Devices Market Outlook, By Urinary and Fecal Incontinence (2021-2030) ($MN)
  • Table 40 Global Neurostimulation Devices Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 41 Global Neurostimulation Devices Market Outlook, By End User (2021-2030) ($MN)
  • Table 42 Global Neurostimulation Devices Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 43 Global Neurostimulation Devices Market Outlook, By Cognitive Care Centers (2021-2030) ($MN)
  • Table 44 Global Neurostimulation Devices Market Outlook, By Specialty Clinics (2021-2030) ($MN)
  • Table 45 Global Neurostimulation Devices Market Outlook, By Research Institutes (2021-2030) ($MN)
  • Table 46 Global Neurostimulation Devices Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.